James D. Griffin (oncologist)
American onocologist
From Wikipedia, the free encyclopedia
James D. Griffin is an American physician-scientist. He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital.[1][2] He is considered an expert in medical oncology and is widely recognized for his research in the clinical and biologic aspects of hemotologic malignancies.
James D. Griffin | |
|---|---|
| Born | James Douglas Griffin |
| Alma mater | |
| Scientific career | |
| Workplaces | |
Education and career
He completed a Bachelor of Arts at Brown University in 1970 and earned an M.D. from Harvard Medical School in 1974. Griffin completed his residency at Johns Hopkins Hospital, a hematology fellowship at Massachusetts General Hospital, and a medical oncology fellowship at Dana–Farber Cancer Institute.[3]
He is on the scientific advisory boards of Phio Pharmaceuticals, the Georgetown Lombardi Comprehensive Cancer Center, and the Johns Hopkins Cancer Center.[4]
Griffin was born in Syracuse, New York. He is a seventh-generation Irish American.[5]
